Upgrade to SI Premium - Free Trial

InMed Pharmaceuticals Inc. (INM)

1.38 +0.05 (3.76%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/10/25 *Est.)

Latest Headlines

Form SCHEDULE 13G InMed Pharmaceuticals Filed by: Ikarian Capital, LLC August 14, 2026 9:12 PM - SEC Filing Form 425 InMed Pharmaceuticals Filed by: InMed Pharmaceuticals Inc. July 22, 2026 4:32 PM - SEC Filing Form 425 InMed Pharmaceuticals Filed by: InMed Pharmaceuticals Inc. July 22, 2026 4:30 PM - SEC Filing Form 8-K InMed Pharmaceuticals For: Jul 22 July 22, 2026 4:28 PM - SEC Filing Mentari Therapeutics raises $200M in private placement tied to INM merger July 22, 2026 7:00 AM - StreetInsider Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline July 22, 2026 7:00 AM - PR NewsWire Form 425 InMed Pharmaceuticals Filed by: InMed Pharmaceuticals Inc. July 20, 2026 4:27 PM - SEC Filing Form 4 InMed Pharmaceuticals For: Jul 15 Filed by: Schneeberger Daniel July 17, 2026 7:29 PM - SEC Filing Form 4 InMed Pharmaceuticals For: Jul 14 Filed by: Vivo Opportunity Cayman Fund, L.P. July 16, 2026 9:58 PM - SEC Filing Form 425 InMed Pharmaceuticals Filed by: InMed Pharmaceuticals Inc. July 10, 2026 4:04 PM - SEC Filing Form 8-K InMed Pharmaceuticals For: Jul 06 July 10, 2026 4:02 PM - SEC Filing InMed amends merger deal with Mentari, files S-4 with SEC July 7, 2026 4:23 AM - StreetInsider InMed Pharmaceuticals and Mentari Therapeutics Announce Amendment to Merger Agreement and Filing of Registration Statement on Form S-4 July 6, 2026 6:22 PM - StreetInsider Form 4 InMed Pharmaceuticals For: Jun 30 Filed by: Vivo Opportunity Fund Holdings, L.P. July 2, 2026 7:02 PM - SEC Filing Form S-4 InMed Pharmaceuticals July 2, 2026 4:03 PM - SEC Filing Imunon names new interim CFO as predecessor retires June 30, 2026 4:40 PM - StreetInsider Form SCHEDULE 13D InMed Pharmaceuticals Filed by: Vivo Opportunity Fund Holdings, L.P. June 10, 2026 9:32 PM - SEC Filing Form 4 InMed Pharmaceuticals For: May 20 Filed by: Vivo Opportunity Cayman Fund, L.P. June 10, 2026 9:15 PM - SEC Filing Form 3 InMed Pharmaceuticals For: May 19 Filed by: Vivo Opportunity Cayman Fund, L.P. June 10, 2026 9:15 PM - SEC Filing Form 8-K InMed Pharmaceuticals For: Jun 03 June 10, 2026 6:03 AM - SEC Filing Full Article List